Open Access
International Journal of Behavioral Nutrition and Physical Activity
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
SCImago
Q1
WOS
Q1
Impact factor
5.6
SJR
2.485
CiteScore
13.8
Categories
Medicine (miscellaneous)
Nutrition and Dietetics
Physical Therapy, Sports Therapy and Rehabilitation
Areas
Health Professions
Medicine
Nursing
Years of issue
2004-2025
journal names
International Journal of Behavioral Nutrition and Physical Activity
INT J BEHAV NUTR PHY
Top-3 citing journals

International Journal of Environmental Research and Public Health
(7345 citations)

BMC Public Health
(6132 citations)

International Journal of Behavioral Nutrition and Physical Activity
(4953 citations)
Top-3 organizations

Deakin University
(247 publications)

Ghent University
(155 publications)

University of Sydney
(138 publications)

Deakin University
(93 publications)

University of Cambridge
(44 publications)

University of Sydney
(44 publications)
Top-3 countries
Most cited in 5 years
Found
Publications found: 8233
Q1

Central Executive Network drives delta-9-tetrahydrocannabinol (THC)-induced nonlinear changes in large-scale functional connectivity in adolescent nonhuman primates
Byun A.J., Deshpande H.U., Stover J., Kangas B.D., Kohut S.J.
Q1
Neuropsychopharmacology
,
2025
,
citations by CoLab: 0

Q1

A new module in the drug development process: preclinical multi-center randomized controlled trial of R-ketamine on alcohol relapse
Meinhardt M.W., Skorodumov I., Jeanblanc J., Benvenuti F., Hilal F.F., Domi E., André C., Bodeau S., Jeanblanc V., Domanegg K., Ciccocioppo R., Naassila M., Spanagel R.
Abstract
The drug development process in psychiatry faces significant challenges due to low reproducibility rates in animal testing, which often leads to translation failures. To address this issue, we introduce a new approach in psychiatric drug development: a preclinical randomized controlled trial (preRCT). To demonstrate its potential utility, we conducted a multi-center preRCT using the alcohol deprivation effect (ADE) model to assess the impact of ketamine and R-ketamine on alcohol relapse across three European research centers. Ketamine (20 mg/kg) significantly reduced relapse, while R-ketamine showed efficacy only in females. A higher dose of R-ketamine (40 mg/kg) was also effective in males. These sex-dependent effects were linked to plasma R-ketamine levels, which were two-fold higher in female compared to male rats. Notably, R-ketamine demonstrated a lasting reduction in alcohol consumption without adverse effects. In conclusion, our preRCT demonstrates R-ketamine’s effectiveness in reducing alcohol relapse and supports translation to a clinical RCT that accounts for sex-dependent effects.
Q1

The crosstalk between CREB and PER2 mediates the transition between mania- and depression-like behavior
Wang X., Ji Y., Li S., Serchov T.
Abstract
Bipolar disorder (BD) is a severe psychiatric disorder characterized by alternating manic and depressive episodes. The molecular mechanisms underlying the transition between mania and depression remain unclear. Utilizing a mania animal model induced by ouabain, we observed reduced phosphorylated level of cyclic AMP-responsive element-binding protein (pCREB) and Period (PER)2 expression in the cornu ammonis (CA1) region of the hippocampus, which were restored by lithium treatment. shRNA knockdown of CREB or Per2 in CA1 region induced mania-like behavior, while overexpression of both factors resulted in depression-like behavior. Furthermore, our protein analyses revealed that the upregulation or downregulation of CREB or Per2 influenced each other’s expression. Co-immunoprecipitation results demonstrated that CREB interacts with PER2. Taken together, our data suggest for potential inter-regulatory crosstalk between CREB–PER2 in hippocampal CA1 region, which mediates the transition between mania- and depression-like behaviors.
Q1

Pharmacological reduction of reverse-translated hippocampal hyperactivity in mouse: relevance for psychosis
Dybowski F.P., Scott D.S., Tamminga C.A.
Q1
Neuropsychopharmacology
,
2025
,
citations by CoLab: 0

Q1

Longitudinal associations between white matter integrity, early life adversities, and treatment response following cognitive-behavioral therapy in depression
Flinkenflügel K., Borgers T., Klug M., Mummendey M.M., Leehr E.J., Meinert S., Gruber M., Repple J., Kircher T., Opel N., Bauer J., Zwiky E., König P., Küttner A., Schöniger K., et. al.
Abstract
Cognitive-behavioral therapy (CBT) is a primary treatment for depression. Although previous research has underscored the significant roles of white matter (WM) alterations and maladaptive parenting in depression risk, their associations with CBT response remain largely unknown. This longitudinal study investigated the interplay of WM integrity changes over time, treatment response, and parenting style in patients with depression. Diffusion-tensor-imaging and clinical data were assessed in n = 65 (55% female) patients with depression before and after 20 CBT sessions and n = 65 (68% female) healthy controls (HC) in a naturalistic design. Linear-mixed-effect models compared changes in fractional anisotropy (FA) between groups and tested associations between FA changes and symptom changes. It was investigated whether parenting style predicts depressive symptoms at follow-up and whether FA changes mediate this association. Patients showed differential FA changes over time in the corpus callosum and corona radiata compared to HC (p
tfce-FWE = 0.008). Increases in FA in the corpus callosum, corona radiata and superior longitudinal fasciculus were linked to symptom improvement after CBT in patients (p
tfce-FWE = 0.023). High parental care (p
FDR = 0.010) and low maternal overprotection (p
FDR = 0.001) predicted fewer depressive symptoms at follow-up. The association between maternal overprotection and depressive symptoms at follow-up was mediated by FA changes (p
FDR = 0.044). Robustness checks—controlling for outliers, non-linear age effects, clinical characteristics, and patient subgroups—supported these results. Overall, patients with depression show changes in WM integrity following CBT, which are linked to treatment response. The results highlight the significance of early life adversities and related microstructural changes in the effectiveness of CBT for treating depression.
Q1

Protein interacting with C-kinase 1 (PICK1) regulates synaptic function and reversal learning in a mouse model for schizophrenia
Samsom J.N., Xu M., Ávila A., Daskalakis A.A., Dai J.H., Gao X., Georgiou J., Collingridge G.L., Liu F., Wong A.H.
Q1
Neuropsychopharmacology
,
2025
,
citations by CoLab: 0

Q1

Prediction of alcohol intake patterns with olfactory and gustatory brain connectivity networks
Agarwal K., Chaudhary S., Tomasi D., Volkow N.D., Joseph P.V.
Abstract
Craving in alcohol drinkers is often triggered by chemosensory cues, such as taste and smell, which are linked to brain network connectivity. This study aimed to investigate whether these brain connectivity patterns could predict alcohol intake in young adults. Resting-state fMRI data were obtained from the Human Connectome Project (HCP) Young Adult cohort, comprising 1003 participants. Functional connectomes generated from 100 independent components were analyzed, identifying significant connections correlated with taste and odor scores after applying a false discovery rate (FDR) correction using the Benjamini-Hochberg (BH) method. These significant connections were then utilized as predictors in general linear models for various alcohol intake metrics. The models were validated in an independent sample to assess their accuracy. The training sample (n = 702) and the validation sample (n = 117) showed no significant demographic differences. Out of 742 possible connections, 41 related to odor and 25 related to taste passed the significance threshold (P < 0.05) after FDR-BH correction. Notable predictors included visual-visual connectivity (node32-node13: β = 0.028, P = 0.02) for wine consumption and connectivity between the ventral attention network (VAN) and the frontal parietal/caudate nucleus (FP/CN) (node27-node9: β = −0.31, P = 0.04) for total alcohol intake in the past-week and maximum number of drinks per day in the past-year. The predictive models demonstrated strong accuracy, with root mean square error (RMSE) values of 5.15 for odor-related models and 5.14 for taste-related models. The F1 scores were 0.74 for the odor model and 0.71 for the taste model, indicating reliable performance. These findings suggest that specific patterns of brain connectivity associated with taste and olfactory perception may serve as predictors of alcohol consumption behaviors in young adults. Our study highlight the need for longitudinal research to evaluate the potential of taste- and smell-related brain connectivity patterns for early screening and targeted interventions, as well as their role in personalized treatment strategies for individuals at risk of AUD.
Q1

REM density predicts rapid antidepressant response to ketamine in individuals with treatment-resistant depression
Kheirkhah M., Duncan W.C., Yuan Q., Wang P.R., Jamalabadi H., Leistritz L., Walter M., Goldman D., Zarate C.A., Hejazi N.S.
Abstract
Abnormalities during rapid eye movement (REM) sleep contribute to the pathophysiology of major depressive disorder (MDD), but few studies have explored the relationship between REM sleep and treatment-resistant depression (TRD). In MDD, REM sleep abnormalities often manifest as alterations in total night REM Density (RD), RD in the first REM period (RD1), and REM Latency (RL). Among these, RD1 is notably considered a potential endophenotype of depression. This study compared REM sleep markers between 63 drug-free individuals with TRD (39 F/24 M) and 41 healthy volunteers (25 F/16 M). It also investigated the effects of ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist, on these REM sleep variables. Specifically, the study investigated whether RD1 could predict antidepressant response to ketamine. TRD participants showed higher RD1 and shorter RL at baseline compared to HVs, as assessed via non-parametric tests, but Total Night RD did not differ between the two groups. Ketamine treatment decreased RD1 in TRD participants but did not affect Total Night RD or RL. As assessed via the Support Vector Machine (SVM) algorithm, baseline RD1 level moderately predicted antidepressant response to ketamine versus non-response (area under the receiver operating characteristic (ROC) curve (AUC) = 0.73, with a median accuracy of 0.75), wherein TRD participants with higher baseline RD1 were more likely to respond to ketamine. These results underscore the utility of RD1 for identifying individuals most likely to benefit from ketamine treatment, enabling more targeted and effective therapeutic strategies. Clinical Trials Identifier: NCT00088699, NCT01204918.
Q1

Frontostriatal regulation of brain circuits contributes to flexible decision making
Duan Y., Ma Z., Tsai P., Lu H., Xiao X., Wang D., Siddiqi A., Stein E.A., Michaelides M., Yang Y.
Abstract
Deficits in behavioral or cognitive flexibility that are linked to altered activity in both cortical and subcortical brain regions, are often observed across multiple neuropsychiatric disorders. The medial prefrontal cortex (mPFC)-nucleus accumbens (NAc) pathway in rats plays a critical role in flexible control of behavior. However, the modulation of this pathway on activity and functional connectivity with the rest of the brain remains unclear. In this study, we first confirmed the role of the mPFC-NAc pathway in behavioral flexibility using a set-shifting task in rats and then evaluated the causal effects of mPFC-NAc activation induced by chemogenetic stimulation of the terminal axons of the NAc with DREADD expression on whole-brain activity and functional connectivity measured by functional MRI. mPFC-NAc activation improved performance on the set-shifting task by reducing perseverative errors. Additionally, stimulation of this pathway increased activity in a set of brain regions within the basal ganglia-thalamus-cortical loop network including NAc, thalamus, hypothalamus and various connected cortical regions, while also decreased functional connectivity strength of NAc-mPFC, NAc-secondary motor cortex (M2), and various cortical circuits. Moreover, performance on the set-shifting task was related to the functional connectivity strength of the above frontostriatal and cortical circuits. These findings provide insights into the link between specific frontostriatal circuits on decision making flexibility, which may inform potential future interventions for behavioral flexibility deficits.
Q1

Validation of L-type calcium channel blocker amlodipine as a novel ADHD treatment through cross-species analysis, drug-target Mendelian randomization, and clinical evidence from medical records
Þorsteinsson H., Baukmann H.A., Sveinsdóttir H.S., Halldórsdóttir D.Þ., Grzymala B., Hillman C., Rolfe-Tarrant J., Parker M.O., Cope J.L., Ravarani C.N., Schmidt M.F., Karlsson K.Æ.
Abstract
ADHD is a chronic neurodevelopmental disorder that significantly affects life outcomes, and current treatments often have adverse side effects, high abuse potential, and a 25% non-response rate, highlighting the need for new therapeutics. This study investigates amlodipine, an L-type calcium channel blocker, as a potential foundation for developing a novel ADHD treatment by integrating findings from animal models and human genetic data. Amlodipine reduced hyperactivity in SHR rats and decreased both hyperactivity and impulsivity in adgrl3.1−/− zebrafish. It also crosses the blood-brain barrier, reducing telencephalic activation. Crucially, Mendelian Randomization analysis linked ADHD to genetic variations in L-type calcium channel subunits (α1-C; CACNA1C, β1; CACNB1, α2δ3; CACNA2D3) targeted by amlodipine, while polygenic risk score analysis showed symptom mitigation in individuals with high ADHD genetic liability. With its well-tolerated profile and efficacy across species, supported by genetic evidence, amlodipine shows potential to be refined and developed into a novel treatment for ADHD.
Q1

Extended amygdala corticotropin-releasing hormone neurons regulate sexually dimorphic changes in pair bond formation following social defeat in prairie voles (Microtus ochrogaster)
Tickerhoof M.C., Nerio Morales L.K., Goff J., Vitale E.M., Smith A.S.
The neurobiological mechanisms underlying the connection between anxiety brought on by social stressors and the negative impact on relationship formation have remained elusive. In order to address this question, we used the social defeat model in the socially monogamous prairie vole to investigate the impact of this stress on pair bond formation. Social defeat experience inhibited partner preference formation in males but promoted preference in females. Furthermore, pair bonding increased corticotropin-releasing hormone (CRH) expression in the bed nucleus of the stria terminalis (BNST) in male prairie voles, while defeat experience increased BNST CRH expression in females. Chemogenetic excitation of BNST CRH neurons during a short cohabitation with a new partner promoted a partner preference in stress-naïve prairie voles. Interestingly, chemogenetic inhibition of BNST CRH neurons during cohabitation with a new partner blocked partner preference in stress-naïve males but promoted preference in defeated males. Inhibition of BNST CRH neurons also blocked partner preference in stress-naïve females but did not alter preference behavior in defeated females. This study revealed sexual dimorphism in not only the impact of social defeat on pair bond formation, but also in the role BNST CRHergic neurons play in regulating changes in pair bonding following social conflict.
Q1

Absence of TAAR1 function increases methamphetamine-induced excitability of dorsal raphe serotonin neurons and drives binge-level methamphetamine intake
Rios S.M., Mootz J.R., Phillips T.J., Ingram S.L.
Abstract
Methamphetamine (MA) is a potent psychostimulant capable of exerting both rewarding and aversive effects, the balance of which likely drives variation in voluntary MA intake. Understanding the genetic factors underlying sensitivity to these effects of MA is critical for developing effective treatments. The activity of dorsal raphe serotonin neurons is linked to reward processing. Here, we performed whole-cell patch-clamp electrophysiology in dorsal raphe serotonin neurons from mice with high or low MA intake corresponding with high or low MA reward sensitivity. The MA drinking (MADR) mice consist of the MA reward sensitive MA high drinking (MAHDR) and the MA reward insensitive MA low drinking (MALDR) lines. MA is a trace amine-associated receptor 1 (TAAR1) agonist, and MAHDR mice are homozygous for a mutation in the Taar1 gene, Taar1
m1J
, that encodes non-functional TAAR1, whereas MALDR mice possess at least one copy of the reference Taar1
+
allele that encodes functional TAAR1. Our previous research using CRISPR-Cas9-generated MAHDR-Taar1
+/+
knock-in mice in which Taar1
m1J
was replaced with Taar1
+
, and non-edited MAHDR-Taar1
m1J/m1J
controls demonstrated that lack of TAAR1 function is critical for heightened MA consumption and MA reward sensitivity. Here, electrophysiological recordings in the MADR lines demonstrate a MA-induced decrease in dorsal raphe serotonin neuron activity from MALDR, but not MAHDR mice. However, in the presence of serotonin autoreceptor antagonists, MA potentiates dorsal raphe serotonin neuron activity of MAHDR, but not MALDR mice. Importantly, potentiation in the presence of the antagonists is abolished in knock-in mice expressing functional TAAR1. The knock-in mice did not display binge-level MA intake, consistent with the loss of MA-reward sensitivity previously reported in mice with functional TAAR1. Finally, because MA is a substrate of the serotonin transporter, we evaluated whether the serotonin transporter is necessary for MA-induced potentiation of dorsal raphe serotonin neuron activity in mice with non-functional TAAR1. The serotonin transporter antagonist fluoxetine blocks MA-induced potentiation for both MAHDR and MAHDR-Taar1
m1J/m1J
mice. Thus, TAAR1 function directly impacts MA reward sensitivity and MA intake and serves as a critical regulator of MA-induced activity of dorsal raphe serotonin neurons through its interaction with the serotonin transporter.
Q1

A molecular mechanism mediating clozapine-enhanced sensorimotor gating
Mantas I., Flais I., Branzell N., Ionescu T.M., Kim E., Zhang X., Cash D., Hengerer B., Svenningsson P.
Abstract
The atypical antipsychotic clozapine targets multiple receptor systems beyond the dopaminergic pathway and influences prepulse inhibition (PPI), a critical translational measure of sensorimotor gating. Since PPI is modulated by atypical antipsychotics such as risperidone and clozapine, we hypothesized that p11—an adaptor protein associated with anxiety- and depressive-like behaviors and G-protein-coupled receptor function—might modulate these effects. In this study, we assessed the role of p11 in clozapine’s PPI-enhancing effect by testing wild-type and global p11 knockout (KO) mice in response to haloperidol, risperidone, and clozapine. We also performed structural and functional brain imaging. Contrary to our expectation that anxiety-like p11-KO mice would exhibit an augmented startle response and heightened sensitivity to clozapine, PPI tests showed that p11-KO mice were unresponsive to the PPI-enhancing effects of risperidone and clozapine. Imaging revealed distinct regional brain volume differences and reduced hippocampal connectivity in p11-KO mice, with significantly blunted clozapine-induced connectivity changes in the CA1 region. Our findings highlight a novel role for p11 in modulating clozapine’s effects on sensorimotor gating and hippocampal connectivity, offering new insight into its functional pathways.
Q1

Brain and cardiovascular responses to acute stress in remitted and recurrent late-life depression
Kraynak T.E., Karim H.T., Banihashemi L., Krafty R.T., Butters M.A., Ajilore O.A., Taylor W.D., Andreescu C.
In individuals with remitted late-life depression (LLD), stress exposure can increase the likelihood of a new, recurrent depressive episode. Variability in the effect of stress on recurrence risk may reflect underlying brain and physiological processes mediating the stress response. We examined how subjective, physiological, and brain responses to an experimental stressor differs in older adults with and without remitted depression, and how these stress responses relate to future relapse. Participants were recruited through 3 sites and included 76 older adults with remitted LLD and 36 age-matched healthy comparison (HC) adults. Participants completed an acute stressor task during functional brain imaging with behavioral and cardiovascular monitoring. Remitted LLD participants were followed longitudinally to evaluate depression recurrence. Compared to HC, the remitted LLD group exhibited reduced stressor-evoked systolic blood pressure and heart rate responses, as well as reduced stressor-evoked posterior insula activity. This blunted stress response phenotype appeared more specific to the stable remitter group than the relapsing LLD group. Survival analyses demonstrated that greater stressor-evoked bed nucleus of the stria terminalis (BNST) activity was associated with faster time to recurrence. These findings add to a growing literature reporting so-called “blunted” stressor-evoked cardiovascular and brain reactivity in remitted depression. Moreover, they link the stress response in visceral interoceptive brain circuits with relapse vulnerability. Future work involving longer follow-up periods may reveal additional stress-related brain and behavioral predictors of recurrence in remitted LLD.
Q1

N-acetylcysteine for youth cannabis use disorder: randomized controlled trial main findings
Gray K.M., Tomko R.L., Baker N.L., McClure E.A., McRae-Clark A.L., Squeglia L.M.
Abstract
Cannabis use disorder is particularly prevalent and impairing among young people, and evidence-based treatments are limited. Prior trials of N-acetylcysteine, added to contingency management as a platform behavioral intervention, yielded positive findings in youth but not in adults. This trial sought to rigorously evaluate whether N-acetylcysteine is efficacious in youth when not paired with a robust behavioral treatment platform. Treatment-seeking youth with cannabis use disorder (N = 192, ages 14–21) were randomized to receive a double-blind 12-week course of oral N-acetylcysteine 1200 mg or placebo twice daily; all received weekly medical management and brief behavioral counseling. The primary efficacy outcome was the proportion of negative urine cannabinoid tests during treatment, compared between groups. An array of self-report and urine testing measures were examined secondarily to assess cannabis use reduction and cessation outcomes. The N-acetylcysteine and placebo groups did not differ in proportion of negative urine cannabinoid tests (RR = 0.93, 95% CI = 0.53, 1.64; p = 0.80) or self-reported cannabis abstinence (RR = 1.02, 95% CI = 0.63, 1.65; p = 0.93) during treatment. The mean percentage of cannabis use days and grams of cannabis used per using day decreased over time during treatment but did not differ between groups. More N-acetylcysteine than placebo treated participants reported gastrointestinal adverse events (63/98 versus 37/94, χ2
1 = 11.9 p < 0.001); adverse events were otherwise similar between groups. Findings indicate that N-acetylcysteine is not efficacious for youth cannabis use disorder when not paired with contingency management, highlighting the potentially crucial role of a robust behavioral treatment platform in facilitating prior positive efficacy findings with N-acetylcysteine.
Trial Registration: Clinicaltrials.gov identifier NCT03055377
Top-100
Citing journals
1000
2000
3000
4000
5000
6000
7000
8000
|
|
International Journal of Environmental Research and Public Health
7345 citations, 5.18%
|
|
BMC Public Health
6132 citations, 4.32%
|
|
International Journal of Behavioral Nutrition and Physical Activity
4953 citations, 3.49%
|
|
Nutrients
3101 citations, 2.19%
|
|
PLoS ONE
3050 citations, 2.15%
|
|
Appetite
2637 citations, 1.86%
|
|
Public Health Nutrition
1698 citations, 1.2%
|
|
BMJ Open
1501 citations, 1.06%
|
|
Frontiers in Public Health
1445 citations, 1.02%
|
|
Journal of Physical Activity and Health
1386 citations, 0.98%
|
|
Preventive Medicine
1381 citations, 0.97%
|
|
Health and Place
1263 citations, 0.89%
|
|
Journal of Transport and Health
1106 citations, 0.78%
|
|
Obesity Reviews
926 citations, 0.65%
|
|
Children
913 citations, 0.64%
|
|
Journal of Medical Internet Research
842 citations, 0.59%
|
|
Sustainability
841 citations, 0.59%
|
|
Frontiers in Psychology
826 citations, 0.58%
|
|
Preventive Medicine Reports
802 citations, 0.57%
|
|
JMIR mHealth and uHealth
751 citations, 0.53%
|
|
Journal of Nutrition Education and Behavior
703 citations, 0.5%
|
|
American Journal of Preventive Medicine
691 citations, 0.49%
|
|
Journal of Sports Sciences
656 citations, 0.46%
|
|
Medicine and Science in Sports and Exercise
651 citations, 0.46%
|
|
Scientific Reports
593 citations, 0.42%
|
|
Psychology of Sport and Exercise
490 citations, 0.35%
|
|
Journal of Aging and Physical Activity
490 citations, 0.35%
|
|
Cochrane Database of Systematic Reviews
488 citations, 0.34%
|
|
Journal of the Academy of Nutrition and Dietetics
465 citations, 0.33%
|
|
Childhood Obesity
455 citations, 0.32%
|
|
Scandinavian Journal of Medicine and Science in Sports
432 citations, 0.3%
|
|
Journal of Science and Medicine in Sport
392 citations, 0.28%
|
|
JMIR Research Protocols
389 citations, 0.27%
|
|
Healthcare
381 citations, 0.27%
|
|
International Journal of Obesity
365 citations, 0.26%
|
|
American Journal of Health Promotion
363 citations, 0.26%
|
|
Journal of Sport and Health Science
355 citations, 0.25%
|
|
Frontiers in Nutrition
353 citations, 0.25%
|
|
Social Science and Medicine
352 citations, 0.25%
|
|
British Journal of Sports Medicine
345 citations, 0.24%
|
|
Applied Physiology, Nutrition and Metabolism
336 citations, 0.24%
|
|
Food Quality and Preference
333 citations, 0.23%
|
|
BMC Pediatrics
331 citations, 0.23%
|
|
Journal of School Health
321 citations, 0.23%
|
|
Sports Medicine
317 citations, 0.22%
|
|
BMC Geriatrics
299 citations, 0.21%
|
|
Obesity
290 citations, 0.2%
|
|
Contemporary Clinical Trials
280 citations, 0.2%
|
|
JMIR Formative Research
280 citations, 0.2%
|
|
Annals of Behavioral Medicine
274 citations, 0.19%
|
|
Health Promotion International
266 citations, 0.19%
|
|
British Journal of Nutrition
266 citations, 0.19%
|
|
International Journal of Health Geographics
262 citations, 0.18%
|
|
Frontiers in Sports and Active Living
258 citations, 0.18%
|
|
Journal of Transport Geography
247 citations, 0.17%
|
|
Mental Health and Physical Activity
242 citations, 0.17%
|
|
American Journal of Clinical Nutrition
241 citations, 0.17%
|
|
Sensors
235 citations, 0.17%
|
|
Pediatric obesity
234 citations, 0.16%
|
|
Journal of Clinical Medicine
223 citations, 0.16%
|
|
Psychology and Health
220 citations, 0.16%
|
|
Journal of Occupational and Environmental Medicine
211 citations, 0.15%
|
|
Trials
202 citations, 0.14%
|
|
Cities
197 citations, 0.14%
|
|
Pilot and Feasibility Studies
197 citations, 0.14%
|
|
European Journal of Public Health
190 citations, 0.13%
|
|
Journal of Adolescent Health
189 citations, 0.13%
|
|
Health Education and Behavior
189 citations, 0.13%
|
|
Journal for the Measurement of Physical Behaviour
187 citations, 0.13%
|
|
Disability and Rehabilitation
186 citations, 0.13%
|
|
Pediatrics
185 citations, 0.13%
|
|
Supportive Care in Cancer
184 citations, 0.13%
|
|
Landscape and Urban Planning
184 citations, 0.13%
|
|
Foods
181 citations, 0.13%
|
|
Journal of Affective Disorders
175 citations, 0.12%
|
|
Translational Behavioral Medicine
175 citations, 0.12%
|
|
Nutrition Reviews
174 citations, 0.12%
|
|
International Journal of Behavioral Medicine
173 citations, 0.12%
|
|
Nutrition Journal
173 citations, 0.12%
|
|
An Introduction to Epidemiology for Health Professionals
171 citations, 0.12%
|
|
American Journal of Public Health
170 citations, 0.12%
|
|
Health Education Research
169 citations, 0.12%
|
|
Eating Behaviors
166 citations, 0.12%
|
|
Digital Health
165 citations, 0.12%
|
|
European Journal of Nutrition
165 citations, 0.12%
|
|
Pediatric Exercise Science
164 citations, 0.12%
|
|
American Journal of Lifestyle Medicine
163 citations, 0.11%
|
|
Journal of Human Nutrition and Dietetics
162 citations, 0.11%
|
|
Journal of American College Health
162 citations, 0.11%
|
|
Urban Forestry and Urban Greening
162 citations, 0.11%
|
|
British Food Journal
161 citations, 0.11%
|
|
Journal of Urban Health
160 citations, 0.11%
|
|
Public Health
155 citations, 0.11%
|
|
Research Quarterly for Exercise and Sport
152 citations, 0.11%
|
|
International Journal of Public Health
147 citations, 0.1%
|
|
Current obesity reports
146 citations, 0.1%
|
|
Journal of Health Psychology
146 citations, 0.1%
|
|
Health Promotion Journal of Australia
145 citations, 0.1%
|
|
Cities & Health
145 citations, 0.1%
|
|
Preventing chronic disease
144 citations, 0.1%
|
|
Show all (70 more) | |
1000
2000
3000
4000
5000
6000
7000
8000
|
Citing publishers
5000
10000
15000
20000
25000
30000
|
|
Springer Nature
28333 citations, 19.96%
|
|
Elsevier
27415 citations, 19.32%
|
|
MDPI
15809 citations, 11.14%
|
|
Wiley
9311 citations, 6.56%
|
|
Taylor & Francis
8895 citations, 6.27%
|
|
SAGE
5483 citations, 3.86%
|
|
JMIR Publications
4699 citations, 3.31%
|
|
Frontiers Media S.A.
4635 citations, 3.27%
|
|
Cambridge University Press
3806 citations, 2.68%
|
|
Public Library of Science (PLoS)
3335 citations, 2.35%
|
|
Oxford University Press
3123 citations, 2.2%
|
|
BMJ
3044 citations, 2.14%
|
|
Ovid Technologies (Wolters Kluwer Health)
2950 citations, 2.08%
|
|
Human Kinetics
2833 citations, 2%
|
|
Mary Ann Liebert
899 citations, 0.63%
|
|
Hindawi Limited
785 citations, 0.55%
|
|
Emerald
753 citations, 0.53%
|
|
Cold Spring Harbor Laboratory
708 citations, 0.5%
|
|
SciELO
708 citations, 0.5%
|
|
American Society for Nutrition
537 citations, 0.38%
|
|
Institute of Electrical and Electronics Engineers (IEEE)
431 citations, 0.3%
|
|
Canadian Science Publishing
394 citations, 0.28%
|
|
American Medical Association (AMA)
316 citations, 0.22%
|
|
Association for Computing Machinery (ACM)
312 citations, 0.22%
|
|
Walter de Gruyter
270 citations, 0.19%
|
|
Georg Thieme Verlag KG
268 citations, 0.19%
|
|
Research Square Platform LLC
240 citations, 0.17%
|
|
American Academy of Pediatrics
234 citations, 0.16%
|
|
IGI Global
221 citations, 0.16%
|
|
S. Karger AG
220 citations, 0.16%
|
|
PeerJ
192 citations, 0.14%
|
|
American Public Health Association
190 citations, 0.13%
|
|
F1000 Research
188 citations, 0.13%
|
|
Centers for Disease Control and Prevention (CDC)
174 citations, 0.12%
|
|
IOS Press
173 citations, 0.12%
|
|
IOP Publishing
138 citations, 0.1%
|
|
Annual Reviews
137 citations, 0.1%
|
|
Bentham Science Publishers Ltd.
113 citations, 0.08%
|
|
Medknow
99 citations, 0.07%
|
|
Scientific Research Publishing
99 citations, 0.07%
|
|
IntechOpen
92 citations, 0.06%
|
|
Social Science Electronic Publishing
91 citations, 0.06%
|
|
Hogrefe Publishing Group
90 citations, 0.06%
|
|
The Japanese Society of Physical Fitness and Sports Medicine
87 citations, 0.06%
|
|
EDP Sciences
78 citations, 0.05%
|
|
American Physiological Society
74 citations, 0.05%
|
|
American Diabetes Association
73 citations, 0.05%
|
|
American Institute of Mathematical Sciences (AIMS)
73 citations, 0.05%
|
|
American Society of Civil Engineers (ASCE)
69 citations, 0.05%
|
|
Japan Epidemiological Association
66 citations, 0.05%
|
|
Palacky University
62 citations, 0.04%
|
|
Dietitians of Canada
61 citations, 0.04%
|
|
Media Sphere Publishing House
61 citations, 0.04%
|
|
Mark Allen Group
60 citations, 0.04%
|
|
The Endocrine Society
58 citations, 0.04%
|
|
AME Publishing Company
56 citations, 0.04%
|
|
American Association for Cancer Research (AACR)
51 citations, 0.04%
|
|
Japan Society for Occupational Health
49 citations, 0.03%
|
|
Nakladatelske Stredisko CLSJE Purkyne
46 citations, 0.03%
|
|
SLACK
43 citations, 0.03%
|
|
National Coordinating Centre for Health Technology Assessment
42 citations, 0.03%
|
|
Environmental Health Perspectives
42 citations, 0.03%
|
|
Maad Rayan Publishing Company
39 citations, 0.03%
|
|
Edizioni Minerva Medica
38 citations, 0.03%
|
|
Ubiquity Press
38 citations, 0.03%
|
|
The Society of Physical Therapy Science
37 citations, 0.03%
|
|
AOSIS
33 citations, 0.02%
|
|
University of Toronto Press Inc. (UTPress)
31 citations, 0.02%
|
|
Baishideng Publishing Group
29 citations, 0.02%
|
|
Royal Society of Chemistry (RSC)
28 citations, 0.02%
|
|
28 citations, 0.02%
|
|
Centre for Evaluation in Education and Science (CEON/CEES)
27 citations, 0.02%
|
|
American Society of Clinical Oncology (ASCO)
26 citations, 0.02%
|
|
Technosdar Ltd
25 citations, 0.02%
|
|
Health Affairs (Project Hope)
24 citations, 0.02%
|
|
The Korean Nutrition Society
24 citations, 0.02%
|
|
Akademiai Kiado
23 citations, 0.02%
|
|
Scandinavian University Press / Universitetsforlaget AS
23 citations, 0.02%
|
|
Brieflands
23 citations, 0.02%
|
|
South Florida Publishing LLC
23 citations, 0.02%
|
|
22 citations, 0.02%
|
|
Oncology Nursing Society
22 citations, 0.02%
|
|
XMLink
22 citations, 0.02%
|
|
The Korean Nutrition Society and The Korean Society of Community Nutrition
22 citations, 0.02%
|
|
American Physical Therapy Association
21 citations, 0.01%
|
|
CSIRO Publishing
21 citations, 0.01%
|
|
Hans Publishers
21 citations, 0.01%
|
|
American Marketing Association
20 citations, 0.01%
|
|
Universidade Federal de Santa Catarina
20 citations, 0.01%
|
|
Korean Academy of Family Medicine
20 citations, 0.01%
|
|
Swedish Nutrition Foundation
20 citations, 0.01%
|
|
Consortium Erudit
20 citations, 0.01%
|
|
Index Copernicus
19 citations, 0.01%
|
|
European Respiratory Society (ERS)
19 citations, 0.01%
|
|
CMA Impact Inc.
19 citations, 0.01%
|
|
The Japanese Society of Nutrition and Dietetics
19 citations, 0.01%
|
|
The Royal Society
18 citations, 0.01%
|
|
University of Chicago Press
18 citations, 0.01%
|
|
Associacao Paulista de Medicina
18 citations, 0.01%
|
|
American College of Physicians
18 citations, 0.01%
|
|
Show all (70 more) | |
5000
10000
15000
20000
25000
30000
|
Publishing organizations
50
100
150
200
250
|
|
Deakin University
247 publications, 9.73%
|
|
Ghent University
155 publications, 6.1%
|
|
University of Sydney
138 publications, 5.44%
|
|
University of Cambridge
136 publications, 5.36%
|
|
Vrije Universiteit Medical Center
115 publications, 4.53%
|
|
University of Melbourne
97 publications, 3.82%
|
|
University of Bristol
96 publications, 3.78%
|
|
Vrije Universiteit Amsterdam
88 publications, 3.47%
|
|
University of Newcastle Australia
86 publications, 3.39%
|
|
University of North Carolina at Chapel Hill
86 publications, 3.39%
|
|
University of Queensland
82 publications, 3.23%
|
|
University of Minnesota
77 publications, 3.03%
|
|
Australian Catholic University
75 publications, 2.95%
|
|
University of South Australia
66 publications, 2.6%
|
|
University of Alberta
63 publications, 2.48%
|
|
University of British Columbia
62 publications, 2.44%
|
|
University of Southern Denmark
60 publications, 2.36%
|
|
Amsterdam University Medical Center
60 publications, 2.36%
|
|
University of California, San Diego
58 publications, 2.28%
|
|
Baker IDI Heart and Diabetes Institute
56 publications, 2.21%
|
|
Harvard University
55 publications, 2.17%
|
|
University of Western Australia
54 publications, 2.13%
|
|
University of Oxford
53 publications, 2.09%
|
|
Maastricht University
53 publications, 2.09%
|
|
University College London
50 publications, 1.97%
|
|
University of Auckland
48 publications, 1.89%
|
|
Erasmus University Medical Center
47 publications, 1.85%
|
|
Children's Nutrition Research Center at Baylor College of Medicine
44 publications, 1.73%
|
|
Loughborough University
43 publications, 1.69%
|
|
University of Edinburgh
42 publications, 1.65%
|
|
University of Hong Kong
42 publications, 1.65%
|
|
Karolinska Institute
40 publications, 1.58%
|
|
University of Oslo
40 publications, 1.58%
|
|
Arizona State University
40 publications, 1.58%
|
|
University of Toronto
40 publications, 1.58%
|
|
University of Ottawa
39 publications, 1.54%
|
|
Monash University
37 publications, 1.46%
|
|
University of Wollongong
36 publications, 1.42%
|
|
Queensland University of Technology
35 publications, 1.38%
|
|
University of Glasgow
35 publications, 1.38%
|
|
Brown University
35 publications, 1.38%
|
|
University of East Anglia
35 publications, 1.38%
|
|
Children's Hospital of Eastern Ontario
35 publications, 1.38%
|
|
University of Victoria
34 publications, 1.34%
|
|
Hunter Medical Research Institute
33 publications, 1.3%
|
|
University of Amsterdam
33 publications, 1.3%
|
|
University of Lisbon
32 publications, 1.26%
|
|
San Diego State University
32 publications, 1.26%
|
|
Leibniz Institute for Prevention Research and Epidemiology
32 publications, 1.26%
|
|
Curtin University
31 publications, 1.22%
|
|
Vrije Universiteit Brussel
31 publications, 1.22%
|
|
University of Calgary
31 publications, 1.22%
|
|
London School of Hygiene & Tropical Medicine
30 publications, 1.18%
|
|
University of Birmingham
30 publications, 1.18%
|
|
Hunter New England Local Health District
30 publications, 1.18%
|
|
University of Washington
30 publications, 1.18%
|
|
Newcastle University
30 publications, 1.18%
|
|
Queen's University at Kingston
30 publications, 1.18%
|
|
University of Zaragoza
28 publications, 1.1%
|
|
University of Exeter
28 publications, 1.1%
|
|
Auckland University of Technology
27 publications, 1.06%
|
|
Flinders University
27 publications, 1.06%
|
|
University of Michigan
27 publications, 1.06%
|
|
University of Helsinki
26 publications, 1.02%
|
|
Swinburne University of Technology
26 publications, 1.02%
|
|
Washington University in St. Louis
26 publications, 1.02%
|
|
Sorbonne Paris Nord University
26 publications, 1.02%
|
|
University of Copenhagen
25 publications, 0.98%
|
|
University of Agder
25 publications, 0.98%
|
|
University of Strathclyde
25 publications, 0.98%
|
|
University of Waterloo
25 publications, 0.98%
|
|
University of Leeds
24 publications, 0.95%
|
|
Katholieke Universiteit Leuven
23 publications, 0.91%
|
|
Victoria University (Australia)
23 publications, 0.91%
|
|
National Cancer Institute
23 publications, 0.91%
|
|
King's College London
22 publications, 0.87%
|
|
Wageningen University and Research Centre
22 publications, 0.87%
|
|
Maastricht University Medical Center+
21 publications, 0.83%
|
|
Norwegian Institute of Public Health
21 publications, 0.83%
|
|
Glasgow Caledonian University
21 publications, 0.83%
|
|
University of Otago
21 publications, 0.83%
|
|
University of Pecs
21 publications, 0.83%
|
|
Queen's University Belfast
21 publications, 0.83%
|
|
University of Bath
21 publications, 0.83%
|
|
Western Sydney University
20 publications, 0.79%
|
|
Pennsylvania State University
20 publications, 0.79%
|
|
Central Queensland University
20 publications, 0.79%
|
|
Harokopio University of Athens
20 publications, 0.79%
|
|
Paris Cité University
20 publications, 0.79%
|
|
Utrecht University
20 publications, 0.79%
|
|
University of Bremen
20 publications, 0.79%
|
|
NIHR Cambridge Biomedical Research Centre
20 publications, 0.79%
|
|
University of Ulster
20 publications, 0.79%
|
|
Sorbonne University
19 publications, 0.75%
|
|
University of Southampton
19 publications, 0.75%
|
|
University of Canberra
19 publications, 0.75%
|
|
University of Navarra
19 publications, 0.75%
|
|
University of Jyväskylä
18 publications, 0.71%
|
|
Stanford University
18 publications, 0.71%
|
|
Tufts University
18 publications, 0.71%
|
|
Show all (70 more) | |
50
100
150
200
250
|
Publishing organizations in 5 years
10
20
30
40
50
60
70
80
90
100
|
|
Deakin University
93 publications, 11.6%
|
|
University of Cambridge
44 publications, 5.49%
|
|
University of Sydney
44 publications, 5.49%
|
|
University of Melbourne
40 publications, 4.99%
|
|
Australian Catholic University
40 publications, 4.99%
|
|
Amsterdam University Medical Center
39 publications, 4.86%
|
|
Vrije Universiteit Amsterdam
37 publications, 4.61%
|
|
University of Newcastle Australia
35 publications, 4.36%
|
|
Ghent University
34 publications, 4.24%
|
|
University of Bristol
33 publications, 4.11%
|
|
University of Queensland
32 publications, 3.99%
|
|
University of Southern Denmark
31 publications, 3.87%
|
|
University of North Carolina at Chapel Hill
30 publications, 3.74%
|
|
University of South Australia
29 publications, 3.62%
|
|
University of British Columbia
23 publications, 2.87%
|
|
Baker IDI Heart and Diabetes Institute
21 publications, 2.62%
|
|
Hunter Medical Research Institute
20 publications, 2.49%
|
|
University of California, San Diego
19 publications, 2.37%
|
|
Leibniz Institute for Prevention Research and Epidemiology
19 publications, 2.37%
|
|
University of Oxford
17 publications, 2.12%
|
|
University of Edinburgh
17 publications, 2.12%
|
|
University of Alberta
17 publications, 2.12%
|
|
University of Ottawa
17 publications, 2.12%
|
|
Norwegian Institute of Public Health
16 publications, 2%
|
|
University of Wollongong
15 publications, 1.87%
|
|
Loughborough University
14 publications, 1.75%
|
|
University of Auckland
14 publications, 1.75%
|
|
Hunter New England Local Health District
14 publications, 1.75%
|
|
University of Hong Kong
14 publications, 1.75%
|
|
Harvard University
14 publications, 1.75%
|
|
University of Bremen
14 publications, 1.75%
|
|
University of Zaragoza
14 publications, 1.75%
|
|
Children's Hospital of Eastern Ontario
14 publications, 1.75%
|
|
University College London
13 publications, 1.62%
|
|
University of Jyväskylä
13 publications, 1.62%
|
|
University of Waterloo
13 publications, 1.62%
|
|
University of Amsterdam
13 publications, 1.62%
|
|
University of Granada
13 publications, 1.62%
|
|
University of Lisbon
12 publications, 1.5%
|
|
University of Helsinki
12 publications, 1.5%
|
|
University of Glasgow
12 publications, 1.5%
|
|
Swinburne University of Technology
12 publications, 1.5%
|
|
University Hospitals Bristol and Weston NHS Foundation Trust
12 publications, 1.5%
|
|
Queen's University at Kingston
12 publications, 1.5%
|
|
University of Minnesota
12 publications, 1.5%
|
|
University of Toronto
12 publications, 1.5%
|
|
University of Calgary
12 publications, 1.5%
|
|
University of Leicester
12 publications, 1.5%
|
|
Imperial College London
11 publications, 1.37%
|
|
Maastricht University
11 publications, 1.37%
|
|
Glasgow Caledonian University
11 publications, 1.37%
|
|
Monash University
11 publications, 1.37%
|
|
University of Western Australia
11 publications, 1.37%
|
|
University of Pecs
11 publications, 1.37%
|
|
Vrije Universiteit Medical Center
11 publications, 1.37%
|
|
University Medical Center Utrecht
11 publications, 1.37%
|
|
Utrecht University
11 publications, 1.37%
|
|
Brown University
11 publications, 1.37%
|
|
University of East Anglia
11 publications, 1.37%
|
|
University of Victoria
11 publications, 1.37%
|
|
University of Navarra
11 publications, 1.37%
|
|
Radboud University Nijmegen Medical Centre
10 publications, 1.25%
|
|
Heidelberg University
10 publications, 1.25%
|
|
Karolinska Institute
10 publications, 1.25%
|
|
University of Gothenburg
10 publications, 1.25%
|
|
Queensland University of Technology
10 publications, 1.25%
|
|
Johns Hopkins University
10 publications, 1.25%
|
|
Arizona State University
10 publications, 1.25%
|
|
Washington University in St. Louis
10 publications, 1.25%
|
|
Children's Nutrition Research Center at Baylor College of Medicine
10 publications, 1.25%
|
|
Wageningen University and Research Centre
10 publications, 1.25%
|
|
University of North Carolina at Charlotte
10 publications, 1.25%
|
|
Katholieke Universiteit Leuven
9 publications, 1.12%
|
|
Chinese Academy of Medical Sciences & Peking Union Medical College
9 publications, 1.12%
|
|
Liverpool John Moores University
9 publications, 1.12%
|
|
University of Liverpool
9 publications, 1.12%
|
|
University of Copenhagen
9 publications, 1.12%
|
|
National University of Singapore
9 publications, 1.12%
|
|
University of Agder
9 publications, 1.12%
|
|
Flinders University
9 publications, 1.12%
|
|
Illawarra Health and Medical Research Institute
9 publications, 1.12%
|
|
Chinese University of Hong Kong
9 publications, 1.12%
|
|
San Diego State University
9 publications, 1.12%
|
|
University of Texas at Austin
9 publications, 1.12%
|
|
Queen's University Belfast
9 publications, 1.12%
|
|
Sorbonne Paris Nord University
9 publications, 1.12%
|
|
University of Bradford
9 publications, 1.12%
|
|
Peking University
8 publications, 1%
|
|
University of Manchester
8 publications, 1%
|
|
Pennsylvania State University
8 publications, 1%
|
|
Curtin University
8 publications, 1%
|
|
University of Tasmania
8 publications, 1%
|
|
The George Institute for Global Health
8 publications, 1%
|
|
University of Southern Queensland
8 publications, 1%
|
|
Newcastle University
8 publications, 1%
|
|
University Medical Center Groningen
8 publications, 1%
|
|
University of Leeds
8 publications, 1%
|
|
University of Valencia
8 publications, 1%
|
|
University of Alabama
8 publications, 1%
|
|
University of Bath
8 publications, 1%
|
|
Show all (70 more) | |
10
20
30
40
50
60
70
80
90
100
|
Publishing countries
100
200
300
400
500
600
700
800
|
|
USA
|
USA, 763, 30.05%
USA
763 publications, 30.05%
|
Australia
|
Australia, 688, 27.1%
Australia
688 publications, 27.1%
|
United Kingdom
|
United Kingdom, 640, 25.21%
United Kingdom
640 publications, 25.21%
|
Netherlands
|
Netherlands, 314, 12.37%
Netherlands
314 publications, 12.37%
|
Canada
|
Canada, 312, 12.29%
Canada
312 publications, 12.29%
|
Belgium
|
Belgium, 189, 7.44%
Belgium
189 publications, 7.44%
|
Norway
|
Norway, 157, 6.18%
Norway
157 publications, 6.18%
|
China
|
China, 135, 5.32%
China
135 publications, 5.32%
|
Germany
|
Germany, 112, 4.41%
Germany
112 publications, 4.41%
|
Spain
|
Spain, 106, 4.17%
Spain
106 publications, 4.17%
|
Denmark
|
Denmark, 93, 3.66%
Denmark
93 publications, 3.66%
|
New Zealand
|
New Zealand, 87, 3.43%
New Zealand
87 publications, 3.43%
|
France
|
France, 83, 3.27%
France
83 publications, 3.27%
|
Sweden
|
Sweden, 69, 2.72%
Sweden
69 publications, 2.72%
|
Brazil
|
Brazil, 68, 2.68%
Brazil
68 publications, 2.68%
|
Finland
|
Finland, 63, 2.48%
Finland
63 publications, 2.48%
|
Ireland
|
Ireland, 60, 2.36%
Ireland
60 publications, 2.36%
|
Portugal
|
Portugal, 49, 1.93%
Portugal
49 publications, 1.93%
|
Switzerland
|
Switzerland, 45, 1.77%
Switzerland
45 publications, 1.77%
|
Japan
|
Japan, 40, 1.58%
Japan
40 publications, 1.58%
|
Italy
|
Italy, 38, 1.5%
Italy
38 publications, 1.5%
|
Hungary
|
Hungary, 28, 1.1%
Hungary
28 publications, 1.1%
|
Singapore
|
Singapore, 24, 0.95%
Singapore
24 publications, 0.95%
|
Greece
|
Greece, 22, 0.87%
Greece
22 publications, 0.87%
|
Chile
|
Chile, 19, 0.75%
Chile
19 publications, 0.75%
|
South Africa
|
South Africa, 19, 0.75%
South Africa
19 publications, 0.75%
|
Austria
|
Austria, 18, 0.71%
Austria
18 publications, 0.71%
|
Colombia
|
Colombia, 18, 0.71%
Colombia
18 publications, 0.71%
|
Mexico
|
Mexico, 18, 0.71%
Mexico
18 publications, 0.71%
|
Estonia
|
Estonia, 15, 0.59%
Estonia
15 publications, 0.59%
|
Cyprus
|
Cyprus, 15, 0.59%
Cyprus
15 publications, 0.59%
|
India
|
India, 13, 0.51%
India
13 publications, 0.51%
|
Kenya
|
Kenya, 13, 0.51%
Kenya
13 publications, 0.51%
|
Poland
|
Poland, 13, 0.51%
Poland
13 publications, 0.51%
|
Nigeria
|
Nigeria, 10, 0.39%
Nigeria
10 publications, 0.39%
|
Czech Republic
|
Czech Republic, 9, 0.35%
Czech Republic
9 publications, 0.35%
|
Iran
|
Iran, 7, 0.28%
Iran
7 publications, 0.28%
|
Malaysia
|
Malaysia, 7, 0.28%
Malaysia
7 publications, 0.28%
|
Slovenia
|
Slovenia, 7, 0.28%
Slovenia
7 publications, 0.28%
|
Israel
|
Israel, 6, 0.24%
Israel
6 publications, 0.24%
|
Bulgaria
|
Bulgaria, 5, 0.2%
Bulgaria
5 publications, 0.2%
|
Saudi Arabia
|
Saudi Arabia, 5, 0.2%
Saudi Arabia
5 publications, 0.2%
|
Thailand
|
Thailand, 5, 0.2%
Thailand
5 publications, 0.2%
|
Iceland
|
Iceland, 4, 0.16%
Iceland
4 publications, 0.16%
|
Costa Rica
|
Costa Rica, 4, 0.16%
Costa Rica
4 publications, 0.16%
|
Peru
|
Peru, 4, 0.16%
Peru
4 publications, 0.16%
|
Republic of Korea
|
Republic of Korea, 4, 0.16%
Republic of Korea
4 publications, 0.16%
|
Barbados
|
Barbados, 3, 0.12%
Barbados
3 publications, 0.12%
|
Indonesia
|
Indonesia, 3, 0.12%
Indonesia
3 publications, 0.12%
|
Luxembourg
|
Luxembourg, 3, 0.12%
Luxembourg
3 publications, 0.12%
|
Mozambique
|
Mozambique, 3, 0.12%
Mozambique
3 publications, 0.12%
|
Uganda
|
Uganda, 3, 0.12%
Uganda
3 publications, 0.12%
|
Uruguay
|
Uruguay, 3, 0.12%
Uruguay
3 publications, 0.12%
|
Fiji
|
Fiji, 3, 0.12%
Fiji
3 publications, 0.12%
|
Sri Lanka
|
Sri Lanka, 3, 0.12%
Sri Lanka
3 publications, 0.12%
|
Bangladesh
|
Bangladesh, 2, 0.08%
Bangladesh
2 publications, 0.08%
|
Vietnam
|
Vietnam, 2, 0.08%
Vietnam
2 publications, 0.08%
|
Ghana
|
Ghana, 2, 0.08%
Ghana
2 publications, 0.08%
|
Jordan
|
Jordan, 2, 0.08%
Jordan
2 publications, 0.08%
|
Lithuania
|
Lithuania, 2, 0.08%
Lithuania
2 publications, 0.08%
|
Pakistan
|
Pakistan, 2, 0.08%
Pakistan
2 publications, 0.08%
|
Tonga
|
Tonga, 2, 0.08%
Tonga
2 publications, 0.08%
|
Ecuador
|
Ecuador, 2, 0.08%
Ecuador
2 publications, 0.08%
|
Argentina
|
Argentina, 1, 0.04%
Argentina
1 publication, 0.04%
|
Bahrain
|
Bahrain, 1, 0.04%
Bahrain
1 publication, 0.04%
|
Brunei
|
Brunei, 1, 0.04%
Brunei
1 publication, 0.04%
|
Venezuela
|
Venezuela, 1, 0.04%
Venezuela
1 publication, 0.04%
|
Guatemala
|
Guatemala, 1, 0.04%
Guatemala
1 publication, 0.04%
|
Grenada
|
Grenada, 1, 0.04%
Grenada
1 publication, 0.04%
|
Cameroon
|
Cameroon, 1, 0.04%
Cameroon
1 publication, 0.04%
|
Lebanon
|
Lebanon, 1, 0.04%
Lebanon
1 publication, 0.04%
|
Malta
|
Malta, 1, 0.04%
Malta
1 publication, 0.04%
|
Morocco
|
Morocco, 1, 0.04%
Morocco
1 publication, 0.04%
|
Mongolia
|
Mongolia, 1, 0.04%
Mongolia
1 publication, 0.04%
|
Nepal
|
Nepal, 1, 0.04%
Nepal
1 publication, 0.04%
|
UAE
|
UAE, 1, 0.04%
UAE
1 publication, 0.04%
|
Oman
|
Oman, 1, 0.04%
Oman
1 publication, 0.04%
|
Palestine
|
Palestine, 1, 0.04%
Palestine
1 publication, 0.04%
|
Puerto Rico
|
Puerto Rico, 1, 0.04%
Puerto Rico
1 publication, 0.04%
|
Romania
|
Romania, 1, 0.04%
Romania
1 publication, 0.04%
|
Seychelles
|
Seychelles, 1, 0.04%
Seychelles
1 publication, 0.04%
|
Suriname
|
Suriname, 1, 0.04%
Suriname
1 publication, 0.04%
|
Tanzania
|
Tanzania, 1, 0.04%
Tanzania
1 publication, 0.04%
|
Philippines
|
Philippines, 1, 0.04%
Philippines
1 publication, 0.04%
|
Ethiopia
|
Ethiopia, 1, 0.04%
Ethiopia
1 publication, 0.04%
|
Show all (55 more) | |
100
200
300
400
500
600
700
800
|
Publishing countries in 5 years
50
100
150
200
250
|
|
Australia
|
Australia, 227, 28.3%
Australia
227 publications, 28.3%
|
USA
|
USA, 208, 25.94%
USA
208 publications, 25.94%
|
United Kingdom
|
United Kingdom, 204, 25.44%
United Kingdom
204 publications, 25.44%
|
Netherlands
|
Netherlands, 94, 11.72%
Netherlands
94 publications, 11.72%
|
Canada
|
Canada, 88, 10.97%
Canada
88 publications, 10.97%
|
China
|
China, 70, 8.73%
China
70 publications, 8.73%
|
Germany
|
Germany, 64, 7.98%
Germany
64 publications, 7.98%
|
Norway
|
Norway, 55, 6.86%
Norway
55 publications, 6.86%
|
Spain
|
Spain, 54, 6.73%
Spain
54 publications, 6.73%
|
Belgium
|
Belgium, 51, 6.36%
Belgium
51 publications, 6.36%
|
Denmark
|
Denmark, 45, 5.61%
Denmark
45 publications, 5.61%
|
Finland
|
Finland, 32, 3.99%
Finland
32 publications, 3.99%
|
France
|
France, 31, 3.87%
France
31 publications, 3.87%
|
Sweden
|
Sweden, 27, 3.37%
Sweden
27 publications, 3.37%
|
Brazil
|
Brazil, 25, 3.12%
Brazil
25 publications, 3.12%
|
New Zealand
|
New Zealand, 25, 3.12%
New Zealand
25 publications, 3.12%
|
Ireland
|
Ireland, 19, 2.37%
Ireland
19 publications, 2.37%
|
Italy
|
Italy, 18, 2.24%
Italy
18 publications, 2.24%
|
Portugal
|
Portugal, 17, 2.12%
Portugal
17 publications, 2.12%
|
Japan
|
Japan, 15, 1.87%
Japan
15 publications, 1.87%
|
Switzerland
|
Switzerland, 14, 1.75%
Switzerland
14 publications, 1.75%
|
Hungary
|
Hungary, 13, 1.62%
Hungary
13 publications, 1.62%
|
Singapore
|
Singapore, 13, 1.62%
Singapore
13 publications, 1.62%
|
Chile
|
Chile, 13, 1.62%
Chile
13 publications, 1.62%
|
Estonia
|
Estonia, 10, 1.25%
Estonia
10 publications, 1.25%
|
Austria
|
Austria, 10, 1.25%
Austria
10 publications, 1.25%
|
Cyprus
|
Cyprus, 10, 1.25%
Cyprus
10 publications, 1.25%
|
Mexico
|
Mexico, 9, 1.12%
Mexico
9 publications, 1.12%
|
Colombia
|
Colombia, 7, 0.87%
Colombia
7 publications, 0.87%
|
South Africa
|
South Africa, 6, 0.75%
South Africa
6 publications, 0.75%
|
Greece
|
Greece, 5, 0.62%
Greece
5 publications, 0.62%
|
Malaysia
|
Malaysia, 5, 0.62%
Malaysia
5 publications, 0.62%
|
Poland
|
Poland, 5, 0.62%
Poland
5 publications, 0.62%
|
Czech Republic
|
Czech Republic, 5, 0.62%
Czech Republic
5 publications, 0.62%
|
Iran
|
Iran, 4, 0.5%
Iran
4 publications, 0.5%
|
Kenya
|
Kenya, 4, 0.5%
Kenya
4 publications, 0.5%
|
Costa Rica
|
Costa Rica, 4, 0.5%
Costa Rica
4 publications, 0.5%
|
Thailand
|
Thailand, 4, 0.5%
Thailand
4 publications, 0.5%
|
Israel
|
Israel, 3, 0.37%
Israel
3 publications, 0.37%
|
Nigeria
|
Nigeria, 3, 0.37%
Nigeria
3 publications, 0.37%
|
Saudi Arabia
|
Saudi Arabia, 3, 0.37%
Saudi Arabia
3 publications, 0.37%
|
Bulgaria
|
Bulgaria, 2, 0.25%
Bulgaria
2 publications, 0.25%
|
India
|
India, 2, 0.25%
India
2 publications, 0.25%
|
Indonesia
|
Indonesia, 2, 0.25%
Indonesia
2 publications, 0.25%
|
Peru
|
Peru, 2, 0.25%
Peru
2 publications, 0.25%
|
Republic of Korea
|
Republic of Korea, 2, 0.25%
Republic of Korea
2 publications, 0.25%
|
Uruguay
|
Uruguay, 2, 0.25%
Uruguay
2 publications, 0.25%
|
Argentina
|
Argentina, 1, 0.12%
Argentina
1 publication, 0.12%
|
Bangladesh
|
Bangladesh, 1, 0.12%
Bangladesh
1 publication, 0.12%
|
Venezuela
|
Venezuela, 1, 0.12%
Venezuela
1 publication, 0.12%
|
Ghana
|
Ghana, 1, 0.12%
Ghana
1 publication, 0.12%
|
Grenada
|
Grenada, 1, 0.12%
Grenada
1 publication, 0.12%
|
Jordan
|
Jordan, 1, 0.12%
Jordan
1 publication, 0.12%
|
Luxembourg
|
Luxembourg, 1, 0.12%
Luxembourg
1 publication, 0.12%
|
Malta
|
Malta, 1, 0.12%
Malta
1 publication, 0.12%
|
Morocco
|
Morocco, 1, 0.12%
Morocco
1 publication, 0.12%
|
Mongolia
|
Mongolia, 1, 0.12%
Mongolia
1 publication, 0.12%
|
UAE
|
UAE, 1, 0.12%
UAE
1 publication, 0.12%
|
Pakistan
|
Pakistan, 1, 0.12%
Pakistan
1 publication, 0.12%
|
Palestine
|
Palestine, 1, 0.12%
Palestine
1 publication, 0.12%
|
Slovenia
|
Slovenia, 1, 0.12%
Slovenia
1 publication, 0.12%
|
Suriname
|
Suriname, 1, 0.12%
Suriname
1 publication, 0.12%
|
Tanzania
|
Tanzania, 1, 0.12%
Tanzania
1 publication, 0.12%
|
Tonga
|
Tonga, 1, 0.12%
Tonga
1 publication, 0.12%
|
Uganda
|
Uganda, 1, 0.12%
Uganda
1 publication, 0.12%
|
Fiji
|
Fiji, 1, 0.12%
Fiji
1 publication, 0.12%
|
Philippines
|
Philippines, 1, 0.12%
Philippines
1 publication, 0.12%
|
Sri Lanka
|
Sri Lanka, 1, 0.12%
Sri Lanka
1 publication, 0.12%
|
Ecuador
|
Ecuador, 1, 0.12%
Ecuador
1 publication, 0.12%
|
Show all (39 more) | |
50
100
150
200
250
|
12 profile journal articles
Ding Ding

University of Sydney
278 publications,
12 430 citations
h-index: 48
2 profile journal articles
IZZICUPO PASCAL
89 publications,
1 612 citations
h-index: 21
1 profile journal article
Ekkekakis Panteleimon

Michigan State University
112 publications,
7 997 citations
h-index: 43
1 profile journal article
Vetrovsky Tomas

Charles University
57 publications,
676 citations
h-index: 15
1 profile journal article
Langfield Tess
11 publications,
61 citations
h-index: 5
1 profile journal article
Medrano María

Public University of Navarre
55 publications,
859 citations
h-index: 15
1 profile journal article
Ferreira Isabel
PhD in Health sciences, Professor
130 publications,
10 436 citations
h-index: 48
Research interests
Epidemiology
1 profile journal article
Vieira Hugo

Universidade Lusófona de Humanidades e Tecnologias
27 publications,
199 citations
h-index: 7